Page 91 - Looking Statement News Today

Energy Transfer Announces Bradford D. Whitehurst as Chief Financial Officer Energy Transfer Announces Bradford D. Whitehurst as Chief Financial Officer Energy Transfer LP (NYSE: ET) today announced that Bradford D. (Brad) Whitehurst has been named as Chief Financial Officer effective immediately. Whitehurst, age 46, brings 20 years of experience to the position having served most recently as Executive Vice President and Head of Tax for the Dallas-based midstream company. In addition to overse...

Half-Year Report on the Liquidity Contract Signed by Lysogene with Kepler Cheuvreux Regulatory News: Lysogene (Paris:LYS) (FR0013233475 LYS ), a Phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, today presents the half-year report on the liquidity contract signed by Lysogene with Kepler Cheuvreux. Under the liquidity contract concluded by LYSOGENE with the Kepler Cheuvreux brokerage firm, as of 31 December 2020, the following assets were held in the liquidit...

Newrange Drilling Expands Mineral Footprint at Pamlico Newrange Gold Corp. is pleased to provide an update on the ongoing reverse circulation drilling program at its Pamlico gold project in Nevada.  The holes reported herein were drilled in the Gold Box Canyon, Merritt, and Good Hope areas and demonstrate the extent of shallow oxide gold mineralization across the Pamlico District, covering an area of approximately 0.75 square kilometers.  Drilling to the end of hole … (TheNewswire) Newran...

Gambier Gold Corp. is pleased to announce it has appointed Mr. Michael Burns as Vice President of Exploration. In addition, Mr. Darin Wagner, former CEO of Balmoral Resources, and Dr. Lee Groat have been invited to serve as technical advisors to the CompanyMr. Michael Schuss, CEO, Gambier Gold statedMr. Burns earned his M.Sc. in Economic Geology from Laurentian University. He has been actively involved in the mining … Gambier Gold Corp. (TSXV:GGAU) (the “Company”) is pleased to announce i...

Gambier Gold Corp. (TSX-V: GGAU) Appoints Michael Burns as VP Exploration and Adds Darin Wagner and Dr. Lee Groat as Technical Advisors TSXV:GGAU) (the " Company") is pleased to announce it has appointed Mr. Michael Burns as Vice President of Exploration. In addition, Mr. Darin Wagner, former CEO of Balmoral Resources, and Dr. Lee Groat have been invited to serve as technical advisors to the Company. Mr. Michael Schuss, CEO, Gambier Gold stated "The addition of Mr. Burns, Mr. Wagner and Dr. Gr...

Merck to Hold Fourth-Quarter and Full-Year 2020 Sales and Earnings Conference Call on February 4 Merck known as MSD outside the United States and Canada, will hold its fourth-quarter and full-year 2020 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EST on Thursday, Feb. 4. During the call, company executives will provide an overview of Merck’s performance for the quarter. Investors, journalists and the general public may access a live audio webcast o...

  Allied Minds plc is an IP commercialisation company focused on early stage company development within the technology sector. With origination relationships that span US federal laboratories, universities, and leading US corporations, Allied Minds historically created, and now manages and funds, a portfolio of companies to generate long-term value for its investors and stakeholders.  Based in Boston, Allied Minds supports its businesses with capital, management, expertise and sh...

Merck Announces Supply Agreement with U.S. Government for Initial Doses of Investigational Biological Therapy for the Treatment of Patients with Severe and Critical COVID-19 Merck known as MSD outside the United States and Canada, today announced it has entered into an agreement with the United States Government to support the development, manufacture and initial distribution of an investigational biological therapeutic upon approval or Emergency Use Authorization from the U.S. Food and Drug Ad...

Cheryl Gault promoted to Chief Operating Officer Amy Schulman stepping down from Board of Directors CAMBRIDGE, Mass., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company developing innovative medicines for people with serious diseases of the central nervous system (CNS), today announced, effective January 1, 2021, the promotions of Cheryl Gault to Chief Operating Officer and Anjeza Gjino to Chief Financial Officer. Bill Huy...

Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene Regulatory News: Lysogene (Paris:LYS) (FR0013233475 LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announces a change in the governance and control of KGA, a company co-owned by Karen Aiach and which currently owns approximately 6% of Lysogenes capital. As part of a reorganization of her personal assets, Karen Aiach, founder and Chief Executive Officer of Lyso...